Annals of the Russian academy of medical sciencesAnnals of the Russian academy of medical sciencesВестник Российской академии медицинских наук0869-60472414-3545"Paediatrician" Publishers LLC20810.15690/vramn.v68i2.542EDITORIALОТ РЕДАКЦИИRESULTS OF THE FEDERAL (NATIONAL) PROJECT FOR PREVENTION AND TREATMENT ESSENTIAL HYPERTENSION PATIENTS IN RUSSIA FROM 2002–2012 YEARSИТОГИ РЕАЛИЗАЦИИ ФЕДЕРАЛЬНОЙ ЦЕЛЕВОЙ ПРОГРАММЫ ПО ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ В РОССИИ В 2002–2012 ГГ.ChazovaI. E.ЧазоваИ. Е.
Russian Federation
tt34@cardio.ruOshchepkovaE. V.ОщепковаЕ. В.
Russian Federation
arthyplab@list.ruRussian Cardiology Research and Production Complex, Moscow, Russian FederationРоссийский кардиологический научно-производственный комплекс, Москва, Российская Федерация22022013682Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciencesВестник Российской академии медицинских наук41107082015Copyright ©; 1970, "Paediatrician" Publishers LLCCopyright ©; 1970, Издательство "Педиатръ"1970"Paediatrician" Publishers LLCИздательство "Педиатръ"https://vestnikramn.spr-journal.ru/jour/about/submissionshttps://vestnikramn.spr-journal.ru/jour/article/view/208

The analysis of measures efficiency for prevention by essential hypertension (EH) in Russian Federation within the space of 2002–2012 years was realized. Those measures were carrying out Federal (National) Project and primary activity of the medical and scientific institutions under the leadership Russian Cardiology Research and Production Complex. The basic result was decrease in cardiovascular disease death rate starting with 2004 year. The most pronounced significant changes were found in death rate from the cerebrovascular diseases. From 2003 to 2012, the annual cerebrovascular disease death rate decreased in 1,5 times (in 2003 — 339,9 by 100 thousands, to compare with 2012 — 224,1 by 100 thousands). Moreover, in 2012 the fatal stroke death rate was decreased on 114,8 thousands (to compare with 2004). Decrease of cardiovascular disease death rate is achieved from: early revealing of essential hypertension pts; development and introduction in practical public health of new methods of prevention («Schools of Health»), adequate diagnostic and treatment of essential hypertension patients; increase of an educational level by cardiology in polyclinics, also use by the government of special purposes for Cardiovascular disease death rate decrease.

Проанализирована эффективность мероприятий по борьбе с артериальной гипертензией в Российской Федерации за период с 2002 по 2012 гг., проводимых в рамках Федеральной целевой программы и основной деятельности медицинских и научных организаций с организационно-методическим руководством Российского кардиологического научно-производственного комплекса как головного учреждения по профилю «Кардиология». Основным достижением явилось снижение смертности населения от болезней системы кровообращения, начиная с 2004 г. Наиболее выраженные позитивные изменения отмечены в смертности от цереброваскулярных болезней, уровень которой снизился в 1,5 раза с 339,9 случаев на 100 тыс. населения в 2003 г. до 224,1 в 2012 г., в т.ч. от фатальных инсультов (уменьшение на 114,8 тыс. случаев по сравнению с 2004 г.). Снижение смертности от болезней системы кровообращения достигнуто за счет: раннего выявления лиц с артериальной гипертензией; разработки и внедрения в практическое здравоохранение новых методов профилактики («Школы здоровья»), диагностики и лечения больных артериальной гипертензией; повышения образовательного уровня врачей первичного звена здравоохранения в области кардиологии, а также использования программно-целевого подхода государства в решении проблемы, направленного на достижение конечного результата — снижения смертности от болезней системы кровообращения.

essential hypertensioncardiovascular disease death ratestroke preventionpreventiondiagnostic and treatment essential hypertensive patientsартериальная гипертензиясердечно-сосудистая смертностьпрофилактика инсультапрофилактикадиагностика и лечение больных артериальной гипертонией1. Heart disease and Stroke statistics ― 2012 update: a report from the American Heart Association. Circulation. 2012; 125: 2–220.2. Chazov E.I. Rukovodstvo po arterial'noi gipertonii [Guidelines for Hypertension]. Moscow, Media-Medika, 2005.3. Chazova I.E. Oshchepkova E.V. Chikhladze N.M. Arterial'naya gipertoniya (printsipy diagnostiki i lecheniya). Pos. dlya vrachei [Hypertension (principles of diagnosis and treatment). Guideline]. Moscow, 2005.4. Bor'ba s arterial'noi gipertoniei. Doklad Komiteta ekspertov VOZ. Vsemirnaya organizatsiya zdravookhraneniya [Control of hypertension. Report of a WHO Expert Committee. World Health Organization]. Geneva, 1996.5. Britov A.N., Oganov R.G. The national program to combat arterial hypertension in the USSR. Ter. arkhiv = Therapeutic archive. 1985; 11: 67.6. Jakovljević D, Sarti C, Sivenius J, Torppa J, Mähönen M, Immonen-Räihä P, Kaarsalo E, Alhainen K, Kuulasmaa K, Tuomilehto J, Puska P, Salomaa V. Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register. Stroke. 2001; 32 (7): 1492–1498.7. Oshchepkova E.V. Federal Target Program "Prevention and treatment of hypertension in the Russian Federation" - 5-year results of its implementation. Zdravookhranenie v Rossiiskoi Federatsii = Health care of the Russian Federation. 2007; 5: 18–21.8. Kalinina A.M., Oshchepkova E.V., Pozdnyakova Yu.M. Evaluating the effectiveness of "School Health" for hypertensive patients in primary care. Profilaktika zabolevanii i ukreplenie zdorov'ya = Disease prevention and health promotion. 2006; 4: 41–47.9. Saltykova M.M., Oshchepkova E.V. Ataullakhanova D.M., Ataullakhanova D.M., Lazareva N.V., Bobokhonova A.S., Rogoza A.N. Electrocardiographic diagnosis of left ventricular hypertrophy in patients with hypertension. Ter. arkhiv = Therapeutic archive. 2006; 78 (12): 40–45.10. Blinova E.V., Sakhnova T.A., Sergakova L.M., Ataullakhanova D.M., Oshchepkova E.V., Lazareva N.V., Aidu E.A.I., Trunov V.G., Titomir L.I. New approaches to the diagnosis of left ventricular hypertrophy by dipole electrocardiotopography ("DECARTO"). Ter. arkhiv = Therapeutic archive. 2005; 4: 8–10.11. Rogoza A.N., Zairova A.R., Oshchepkova E.V. Measurement of pulse wave velocity with reactive hyperemia as a method of vasomotor endothelial function in hypertensive patients. Ter. arkhiv = Therapeutic archive. 2008; 4: 29–33.12. Rogoza A.N., Oshchepkova E.V., Tsagareishvili E.V., Gorieva Sh.B. Sovremennye neinvazivnye metody izmereniya arterial'nogo davleniya dlya diagnostiki arterial'noi gipertonii i otsenki effektivnosti antigipertenzivnoi terapii. Pos. dlya vrachei [Current non-invasive measurement of blood pressure for hypertension and diagnostic evaluation of antihypertensive therapy. Guideline]. Moscow, 2007.13. Danilov N.M., Chazova I.E., Savchenko A.P. Renovascular hypertension: diagnosis and treatment. Sistemnye gipertenzii = Systemic hypertension. 2009; 1: 71–73.14. Chazova I.E., Litvin A.Yu. Obstructive sleep apnea syndrome and related cardiovascular complications. Kardiologiya = Cardiology. 2002; 11: 86–92.15. Bolotova M.N., Galitsin P.V.. Kolos I.P., Litvin A.Yu., Chazova I.E. Obstructive sleep apnea as an independent risk factor for cardiovascular complications. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prevention. 2009; 5: 103–112.16. Chazova I.E., Mychka V.B. Metabolic syndrome. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prevention. 2003; 3: 32–38.17. Mamyrbaeva K.M., Mychka V.B., Chazova I.E. Hypertension and metabolic syndrom. Consilium medicum = Consilium medicum. 2004; 5: 320–323.18. Prokopovich M.E., Varakin Yu.Ya., Oshchepkova E.V., Rebrova O.Yu. Prognostic factors of acute cerebrovascular events in hypertensive disease. Ter. arkhiv = Therapeutic archive. 2006; 10: 14–18.19. Suslina Z.A., Varakin Yu.Ya., Maksimova M.Yu., Oshchepkova E.V. Conceptual framework for prevention of vascular diseases of the brain. Klinicheskaya farmakologiya i terapiya = Clinical pharmacology and therapy. 2004; 5: 35–43.20. Varakin Yu.Ya. Profilaktika ONMK. Insul't: diagnostika, lechenie, profilaktika. 2-e izd. Monografiya pod red. Z.A. Suslinoi, M.A. Piradova [Prevention of stroke. Stroke: diagnosis, treatment, prevention. 2nd ed. Monograph edited by Z.A. Suslina, M.A. Piradov]. Moscow, MEDPress-inform, 2009. pp. 155–196.21. Chazova I.E., Ostroumova O.D. FLUTE - Russian comparative multicenter, randomized, open the program to evaluate the efficacy and safety of treatment of patients with hypertension and cognitive impairment fixed combination drug "Tarka» (Abbott Laboratories, USA) compared with arbitrary long-acting antihypertensive drugs ("step by step" strategy). Sistemnye gipertenzii = Systemic hypertension. 2009; 4: 34–36.22. Chazova I.E., Martynyuk T.V. Optimization of antihypertensive therapy in hypertensive patients at high risk: the new Russian program "Strategy A". Sistemnye gipertenzii = Systemic hypertension. 2010; 2: 47–52.23. Chazova I.E., Fomin V.V., Razuvaeva M.A., Vigdorchik A.V. Resistant and uncontrolled hypertension in the Russian Federation: epidemiological characteristics and treatment approaches (Russian Register of uncontrolled and resistant hypertension "Regatta"). Kardiologicheskii vestnik = Cardiac bulletin. 2011; 1: 40–48.24. Chazova I.E., Martynyuk T.V., Kolos I.P. The first results of the Russian program "Strategy" in patients with hypertension: evaluation of the effectiveness Noliprel with insufficient control of blood pressure. Consilium medicum = Consilium medicum. 2007; 5: 5–9.25. Chazova I.E., Ratova L.G., Galyavich A.S., Gapon L.I., Ivashkin V.T., Katel'nitskaya L.I., Martsevich S.Yu., Nedogoda S.V., Nikitin Yu.P., Oganov R.G., Petrichko T.A., Simonova G.I., Sokolov I.M., Fomin I.V., Shlyakhto E.V, Yakusevich V.V. The effectiveness of antihypertensive therapy in hypertensive patients, depending on the risk of cardiovascular complications. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prevention. 2008; 2: 78–82.26. Chazova I.E., Belenkov Yu.N., Ratova L.G. The effectiveness of antihypertensive therapy in hypertensive patients, depending on the risk of cardiovascular complications. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prevention. 2005; 4: 4–14.27. Dovgalevskii P.Ya., Oshchepkova E.V., Gridnev V.I. Register hypertension. Ter. arkhiv = Therapeutic archive. 2007; 1: 46–48.